hrcak mascot   Srce   HID

Kratko priopćenje
https://doi.org/10.2478/acph-2022-0011

Initiation of insulin therapy in patients with type 2 diabetes: An observational study

SPELA ZEROVNIK ; University of Ljubljana, Faculty of Pharmacy, Slovenia
MITJA KOS ; University of Ljubljana, Faculty of Pharmacy, Slovenia
IGOR LOCATELLI ; University of Ljubljana, Faculty of Pharmacy, Slovenia

Puni tekst: engleski, pdf (390 KB) str. 147-157 preuzimanja: 59* citiraj
APA 6th Edition
ZEROVNIK, S., KOS, M. i LOCATELLI, I. (2022). Initiation of insulin therapy in patients with type 2 diabetes: An observational study. Acta Pharmaceutica, 72 (1), 147-157. https://doi.org/10.2478/acph-2022-0011
MLA 8th Edition
ZEROVNIK, SPELA, et al. "Initiation of insulin therapy in patients with type 2 diabetes: An observational study." Acta Pharmaceutica, vol. 72, br. 1, 2022, str. 147-157. https://doi.org/10.2478/acph-2022-0011. Citirano 28.11.2021.
Chicago 17th Edition
ZEROVNIK, SPELA, MITJA KOS i IGOR LOCATELLI. "Initiation of insulin therapy in patients with type 2 diabetes: An observational study." Acta Pharmaceutica 72, br. 1 (2022): 147-157. https://doi.org/10.2478/acph-2022-0011
Harvard
ZEROVNIK, S., KOS, M., i LOCATELLI, I. (2022). 'Initiation of insulin therapy in patients with type 2 diabetes: An observational study', Acta Pharmaceutica, 72(1), str. 147-157. https://doi.org/10.2478/acph-2022-0011
Vancouver
ZEROVNIK S, KOS M, LOCATELLI I. Initiation of insulin therapy in patients with type 2 diabetes: An observational study. Acta Pharm. [Internet]. 2022 [pristupljeno 28.11.2021.];72(1):147-157. https://doi.org/10.2478/acph-2022-0011
IEEE
S. ZEROVNIK, M. KOS i I. LOCATELLI, "Initiation of insulin therapy in patients with type 2 diabetes: An observational study", Acta Pharmaceutica, vol.72, br. 1, str. 147-157, 2022. [Online]. https://doi.org/10.2478/acph-2022-0011

Sažetak
The aim of the study was to assess the initiation of insulin therapy in patients with type 2 diabetes using health claims data on prescription medicines. The study evaluated time to insulin initiation and prescribing patterns of other antidiabetic medicines before and after insulin initiation. Five years after starting non-insulin antidiabetic therapy, 6.4 % of patients were prescribed insulin, which is substantially lower compared to other similar studies. Among all patients who initiated insulin therapy in 2013, 30 % did not continue any other antidiabetic therapy. However, this proportion was lowered to 20 % in 2018. Before insulin initiation in 2018, metformin was prescribed in only 67 % of patients and sulfonylureas in 78 % of patients. Moreover, metformin and sulfonylureas were discontinued after insulin initiation in 26 and 37 % of patients, resp. More attention should be paid to the continuation of oral antidiabetics, particularly metformin, after insulin initiation.

Ključne riječi
diabetes mellitus; insulin; metformin; sulfonylurea

Hrčak ID: 261414

URI
https://hrcak.srce.hr/261414

Posjeta: 120 *